Skip to content
Who Really Needs Ozempic Anyway? episode artwork

May 20, 2026 59 min

Who Really Needs Ozempic Anyway?

from Prosthetic Gods Hosted by James Hughes and Nir Eisikovits

Episode 42 - Who Really Needs Ozempic Anyway? This week on Prosthetic Gods, Nir and J discuss the tradeoffs of GLP1 drugs. Their use has reversed the obesity epidemic and has proven to have myriad medical and psychological benefits. But they also come with risks, and are seen as a technofix replacing the need for diets. Are GLP1s another step to the posthuman body, and is that a good or bad thing? Errata: The first GLP1s were approved by the FDA in 2005, semaglutide/Ozempic in 2017, and oral orforglipron/Foundayo was approved in April 2026. More than two thirds of American adults are overweight or obese by BMI, and 40% are obese. Show Notes: GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show Ethical Considerations in the Use of Weight Loss Medications The Ethics of Ozempic and Wegovy WHO issues global guideline on the use of GLP-1 medicines in treating obesity Review of 64 studies finds GLP1s effective for weight loss for almost all groups Obesity rate declining in US Hard Fork Podcast Rest is History Podcast As always, listeners can contact us at [email protected] with questions, comments, and suggestions for future topics. Credits: Hosted by James Hughes and Nir Eisikovits Music & Production by Jake Burley

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Who Really Needs Ozempic Anyway?

0:00 59:26

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Prosthetic Gods?

This episode is 59 minutes long.

When was this Prosthetic Gods episode published?

This episode was published on May 20, 2026.

Can I download this Prosthetic Gods episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.